Dynamics of oligodendrocyte generation in multiple sclerosis
- PMID: 30675058
- PMCID: PMC6420067
- DOI: 10.1038/s41586-018-0842-3
Dynamics of oligodendrocyte generation in multiple sclerosis
Erratum in
-
Publisher Correction: Dynamics of oligodendrocyte generation in multiple sclerosis.Nature. 2019 Feb;566(7744):E9. doi: 10.1038/s41586-019-0935-7. Nature. 2019. PMID: 30723267
Abstract
Oligodendrocytes wrap nerve fibres in the central nervous system with layers of specialized cell membrane to form myelin sheaths1. Myelin is destroyed by the immune system in multiple sclerosis, but myelin is thought to regenerate and neurological function can be recovered. In animal models of demyelinating disease, myelin is regenerated by newly generated oligodendrocytes, and remaining mature oligodendrocytes do not seem to contribute to this process2-4. Given the major differences in the dynamics of oligodendrocyte generation and adaptive myelination between rodents and humans5-9, it is not clear how well experimental animal models reflect the situation in multiple sclerosis. Here, by measuring the integration of 14C derived from nuclear testing in genomic DNA10, we assess the dynamics of oligodendrocyte generation in patients with multiple sclerosis. The generation of new oligodendrocytes was increased several-fold in normal-appearing white matter in a subset of individuals with very aggressive multiple sclerosis, but not in most subjects with the disease, demonstrating an inherent potential to substantially increase oligodendrocyte generation that fails in most patients. Oligodendrocytes in shadow plaques-thinly myelinated lesions that are thought to represent remyelinated areas-were old in patients with multiple sclerosis. The absence of new oligodendrocytes in shadow plaques suggests that remyelination of lesions occurs transiently or not at all, or that myelin is regenerated by pre-existing, and not new, oligodendrocytes in multiple sclerosis. We report unexpected oligodendrocyte generation dynamics in multiple sclerosis, and this should guide the use of current, and the development of new, therapies.
Conflict of interest statement
The authors declare no competing financial interests.
Figures












Comment in
-
Time to revisit oligodendrocytes in multiple sclerosis.Nat Med. 2019 Mar;25(3):364-366. doi: 10.1038/s41591-019-0388-4. Nat Med. 2019. PMID: 30804516 No abstract available.
Similar articles
-
Altered human oligodendrocyte heterogeneity in multiple sclerosis.Nature. 2019 Feb;566(7745):543-547. doi: 10.1038/s41586-019-0903-2. Epub 2019 Jan 23. Nature. 2019. PMID: 30747918 Free PMC article.
-
BCAS1-positive oligodendrocytes enable efficient cortical remyelination in multiple sclerosis.Brain. 2025 Mar 6;148(3):908-920. doi: 10.1093/brain/awae293. Brain. 2025. PMID: 39319704 Free PMC article.
-
Cortical remyelination: a new target for repair therapies in multiple sclerosis.Ann Neurol. 2012 Dec;72(6):918-26. doi: 10.1002/ana.23693. Epub 2012 Oct 17. Ann Neurol. 2012. PMID: 23076662 Free PMC article.
-
Oligodendrocytes in Development, Myelin Generation and Beyond.Cells. 2019 Nov 12;8(11):1424. doi: 10.3390/cells8111424. Cells. 2019. PMID: 31726662 Free PMC article. Review.
-
The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination.Adv Exp Med Biol. 1999;468:183-97. doi: 10.1007/978-1-4615-4685-6_15. Adv Exp Med Biol. 1999. PMID: 10635029 Review.
Cited by
-
Dabrafenib Promotes Schwann Cell Differentiation by Inhibition of the MEK-ERK Pathway.Molecules. 2021 Apr 8;26(8):2141. doi: 10.3390/molecules26082141. Molecules. 2021. PMID: 33917810 Free PMC article.
-
Genetic models of cleavage-reduced and soluble TREM2 reveal distinct effects on myelination and microglia function in the cuprizone model.J Neuroinflammation. 2023 Feb 8;20(1):29. doi: 10.1186/s12974-022-02671-z. J Neuroinflammation. 2023. PMID: 36755323 Free PMC article.
-
Endogenous Neural Stem Cell Mediated Oligodendrogenesis in the Adult Mammalian Brain.Cells. 2022 Jul 2;11(13):2101. doi: 10.3390/cells11132101. Cells. 2022. PMID: 35805185 Free PMC article. Review.
-
ALCAM on human oligodendrocytes mediates CD4 T cell adhesion.Brain. 2024 Jan 4;147(1):147-162. doi: 10.1093/brain/awad286. Brain. 2024. PMID: 37640028 Free PMC article.
-
Extrinsic Factors Driving Oligodendrocyte Lineage Cell Progression in CNS Development and Injury.Neurochem Res. 2020 Mar;45(3):630-642. doi: 10.1007/s11064-020-02967-7. Epub 2020 Jan 29. Neurochem Res. 2020. PMID: 31997102 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical